Mark Rothera, Chief Commercial Officer at PTC THERAPEUTICS, INC. (PTCT), sold 300 shares at $76.36 ($23K) on 2015-03-13, disclosed to the SEC on 2015-03-13.
Scheduled sale ($23k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PTCT | SELL | 2015-03-18 | $820K | — | Filing → |
| PTCT | SELL | 2015-02-25 | $2.4M | — | Filing → |
| PTCT | SELL | 2015-01-22 | $180K | — | Filing → |